United States · FDA National Drug Code directory
Prochlorperazine Edisylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 23155-523_d30b8909-61fc-4d53-9a53-0f8612bc2754
- Product NDC
- 23155-523
- Form
- INJECTION
- Composition / generic term
- Prochlorperazine Edisylate
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150626
- Source listing expiry
- 20261231
Source-listed ingredients
- PROCHLORPERAZINE EDISYLATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 PACKAGE (23155-523-41) / 2 mL in 1 VIAL (23155-523-31) · 23155-523-41
- 25 VIAL in 1 PACKAGE (23155-523-42) / 2 mL in 1 VIAL (23155-523-31) · 23155-523-42
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →